Home Newsfeeds Barclays Maintains Overweight on Element Solutions, Lowers Price Target to $21

Barclays Maintains Overweight on Element Solutions, Lowers Price Target to $21

Barclays analyst Michael Leithead maintains Element Solutions (NYSE:ESI) with a Overweight and lowers the price target from $22 to $21.

byBenzinga Newsdesk

November 1, 2022

1 minute read

Barclays analyst Michael Leithead maintains Element Solutions (NYSE:ESI) with a Overweight and lowers the price target from $22 to $21.

Teva Appoints Dr. R. Ananthanarayanan As New CEO For Teva API, Its Active Pharmaceutical Ingredients Business

By Benzinga Newsdesk

November 7, 6:44 PM

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead

TEVA

Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report

By Vandana Singh

February 20, 2:24 PM

Teva Pharmaceutical Industries confirms unity and dispels split rumors. CEO Richard Francis emphasizes the synergy between generics and branded drugs.

TEVA

News

REGIONAL Federal Credit Union Selects Upstart For Personal Lending

By Benzinga Newsdesk

November 15, 10:13 AM

REGIONAL federal credit union, a community-based credit union focused on serving Lake and Porter counties, has announced a new partnership with Upstart (NASDAQ:UPST), the leading artificial intelligence (AI) lending

UPST

Market Volatility Increases After Earnings Reports; S&P 500 Closes Higher

By Lisa Levin

July 20, 5:43 AM

The S&P 500 closed higher on Wednesday, as investors assessed recent earnings reports. Shares of The Goldman Sachs Group, Inc. (NYSE: GS) gained around 1% after releasing results for its second quarter.

Barclays Maintains Overweight on Element Solutions, Lowers Price Target to $21

Related Posts

Teva Appoints Dr. R. Ananthanarayanan As New CEO For Teva API, Its Active Pharmaceutical Ingredients Business

Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report

REGIONAL Federal Credit Union Selects Upstart For Personal Lending

Market Volatility Increases After Earnings Reports; S&P 500 Closes Higher